DNA and gene cloning services market worth $12.15 billion by 2030

JERSEY CITY, NJ, August 25, 2022 /PRNewswire/ — InsightAce Analytic Pvt. announced the publication of a market research report entitled “Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Subcloning, Gene Synthesis and Others), Gene Type (Complex Gene, Standard Gene and Others), Industry end user (pharmaceutical, academic and R&D, and biotech companies, and others) – Market Outlook and Industry Analysis 2030″ According to the latest research from the company, the global DNA and gene cloning services market is worth US$2.80 billion in 2021 and is expected to reach US$12.15 billion in 2030, with a promising CAGR of 18.22% between 2022 and 2030.

InsightAce analytics logo

Get sample copy of the Global DNA and Gene Cloning Services Market Report at https://www.insightaceanalytic.com/request-sample/1357

Many scientific processes begin with the synthesis and cloning of genes. DNA amplification by subcloning and polymerase chain reaction are two standard techniques for gene cloning. The DNA cloning method is simply the recombinant DNA technology, which combines the DNA of two organisms into a single molecule. This recombinant DNA is inserted into the desired organism to produce hybrid offspring. DNA cloning is used for protein production, genetic analysis and gene therapy. The method of gene cloning involves isolating all of an organism’s DNA, then locating and copying (or “cloning”) a specific gene of interest from that DNA. DNA cloning includes extraction of plasmid DNA, restriction enzymes and living cell for multiplication of newly formed DNA. The polymerase chain reaction (PCR) is widely used for cloning purposes. In genetic engineering, “gene cloning” refers to the creation of synthetic copies of a gene. Gene cloning can be done in two ways, in vivo and in vitro. Many human genes have been successfully cloned in E. coli or yeasts, allowing the production of an infinite number of human proteins in vitro. More than 100 drugs for human therapy are made from cultured cells (E. coli, yeast, and mammalian cells) modified with a human gene. Cloning is a revolutionary technique in the field of biotechnology. It helps mankind in many ways and many chronic diseases are treated using this technique which increases the lifespan. A healthy and better life is achieved through this genetic development. In agricultural applications, crops are improved daily, leading to better nutrient values.

The market for DNA and gene cloning services is expected to grow gradually in the coming years. This is due to the growing acceptance of gene therapies and the development and application of new cutting-edge DNA cloning technology. These two things are likely to drive the market for DNA and gene cloning services. The market is also propelled by an increase in the number of companies entering the field and spending on research and development, the growing prevalence of chronic and hereditary diseases, coupled with a growing need for personalized medicine. A favorable funding framework for gene synthesis and cloning services, technological advancements in cloning and subcloning services, and increasing synergistic market activities are among the aspects that have driven the expansion of the business. industry over the forecast period.

In the coming years, the global gene synthesis market may be hampered by a lack of qualified personnel and stringent and time-consuming approval procedures. Technological advancements, strategic partnerships, and acquisitions in the biomedical and healthcare sectors could present the market with intriguing opportunities. However, high investments, financings and collaborations for industrial growth are expected during the projection period, as North America prioritizes the use of DNA and gene cloning in the life science research industry.

The important companies in the market are Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience, Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc., Bio-Rad and others player keys.

Curious about this latest version of the report? For more information @ https://www.insightaceanalytic.com/customization/1357

Key Market Developments

  • In Jan 2021, Codex DNA and Pfizer have signed a collaboration and early access license agreement, which will allow Pfizer to use CodexDNA’s novel enzymatic DNA synthesis technology in its research and development of vaccines and biotherapies based on DNA. mRNA. Codex DNA will be responsible for continuing the development of the technology.

  • Inot May 2020, GenScript has just launched a GMP single-stranded and double-stranded DNA service to help grow gene and cell therapies. The announcement underscores GenScript’s commitment to assisting the comprehensive development of non-viral cell therapy through the clinical and activation stages of IND.

  • In Dec 2020, ThermoFisher increased its clinical and commercial capabilities for manufacturing plasmid DNA. The commercialization of plasmid-based drugs and vaccines will be accelerated by the opening of a new cGMP facility in Carlsbad, California. The facility will also be able to generate large amounts of plasmid DNA, which is a crucial component of drugs used in DNA treatments. This growth builds on the company’s continued commitment to providing cell and gene therapy services.

  • In May 2020, Takara Organic announced a collaboration with AGC Biologics. The companies will collaborate on a prophylactic DNA vaccine against COVID-19, with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.

Get report details @ https://www.insightaceanalytic.com/enquiry-before-buying/1357

Market segmentation :

Global DNA and Gene Cloning Services Market, By Type of service offered2022-2030 (Value in US$ millions)

  • Custom Cloning

  • Gene synthesis

  • Subcloning

  • Others

Global DNA and Gene Cloning Services Market, By gene type2022-2030 (Value in US$ millions)

  • complex gene

  • standard gene

  • Others

Global DNA and Gene Cloning Services Market, By End user industry2022-2030 (Value in US$ millions)

Global DNA and Gene Cloning Services Market, By Region2022-2030 (Value in US$ millions)

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

North America DNA and Gene Cloning Services Market, By Country2022-2030 (Value in US$ millions)

European DNA and Gene Cloning Services Market, By Country2022-2030 (Value in US$ millions)

  • Germany

  • France

  • Italy

  • Spain

  • Russia

  • Rest of Europe

Asia-Pacific DNA and Gene Cloning Services Market, By Country2022-2030 (Value in US$ millions)

  • India

  • China

  • Japan

  • South Korea

  • Australia & New Zealand

Latin America DNA and Gene Cloning Services Market, By Country2022-2030 (Value in US$ millions)

  • Brazil

  • Mexico

  • Rest of Latin America

Middle East and the market for DNA and gene cloning services in Africa, for Country2022-2030 (Value in US$ millions)

For more information @ https://www.insightaceanalytic.com/customization/1357

Other related reports published by InsightAce Analytics:

Global market for cell and gene therapy drug delivery devices

Global Circulating Free DNA (ccfDNA) Diagnostics Market

Global market for cell and gene therapy bioassay services

Why buy this report:

  • To receive a comprehensive outlook analysis of the Global DNA and Gene Cloning Services Market

  • To receive industry insight and future trends in the DNA and Gene Cloning Services market

  • To analyze DNA and Gene Cloning Services market drivers and challenges

  • For insight into the DNA and Gene Cloning Services Market Size (Value in Million US$) forecasted till 2030

  • To gain insight on significant investments, mergers, and acquisitions in the DNA and Gene Cloning Services Market industry

About Us:

InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market intelligence and competition to grow businesses. We help our clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in delivering syndicated and customized market intelligence reports with in-depth analysis with key market insights in a timely and cost effective manner.

Contact us:
InsightAce Analytics Pvt. ltd.
Such. : +1 551 226 6109
Email: [email protected]
Site visit: www.insightaceanalytic.com
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

Quote

Quote

View original content: https://www.prnewswire.com/news-releases/dna-and-gene-cloning-services-market-worth-12-15-billion-by-2030—exclusive-report-by -insightace-analytic-301612427.html

SOURCE InsightAce Analytics Pvt. ltd.

About Norman Griggs

Check Also

10 Memes That Sum Up The Jurassic Park Movies Perfectly

It seems like the worst thing that happened to the dinosaurs after the asteroid disappeared …